EP0206567A2 — Compounds of formula [1,1'-biphenyl]-2-carboxylic acid, 2'-[[[(substituted)phenyl]-(substituted)amino]carbonyl]-, pharmaceutical compositions comprising the compounds, and a process for preparing the compounds
Assigned to Warner Lambert Co LLC · Expires 1986-12-30 · 39y expired
What this patent protects
The present invention provides various novel diphenic acid monoamide compounds of the formulaAlso provided are novel pharmaceutical compositions comprising . the compounds and novel methods for synthesising the compounds. The novel diphenic acid monoamides of the present inventio…
USPTO Abstract
The present invention provides various novel diphenic acid monoamide compounds of the formulaAlso provided are novel pharmaceutical compositions comprising . the compounds and novel methods for synthesising the compounds. The novel diphenic acid monoamides of the present invention areleukotriene antagonists, 5-lipoxygenase inhibitors, and mediator release inhibitors providing activity useful for treating asthma, allergies, cardiovascular diseases, migraines, and immunoinflammatory conditions.
Drugs covered by this patent
- Jardiance (empagliflozin) · Boehringer Ingelheim
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.